Kristin has been managing intellectual property and commercialization for UCSF since 2008. Her portfolio of technologies includes therapeutics, diagnostics, and medical devices. She works closely with UCSF faculty and staff to develop and commercialize their inventions, build large research collaboration and licensing partnerships, and spin out companies. In addition, she negotiates and drafts IP agreements including licenses, options, inter-institutional agreements, CDAs and MTAs.
Kristin holds a Ph.D. in Virology from Harvard University and an A.B. in Molecular Biology from Princeton University. She has hands-on research experience in HIV pathogenesis, cell signaling, cell biology, mouse genetics and Drosophila development and speciation. She also has experience in business strategy consulting in the biotechnology and pharmaceutical space and in science and technology policy at the National Academies.
Kristin is excited about helping UCSF researchers succeed in translation of their cutting edge research into technologies that will advance health worldwide.